Comparison
Belle vs Hims
Independent, side-by-side. Same methodology, same sourcing standard, no payment accepted from either. Prices are observed market pricing (snapshot 2026-07-20); receipts are computed from sourced records.
| Belle | Hims | |
|---|---|---|
| Verdict | Profile in progress | Profile in progress |
| Tirzepatide price | from $199/mo (6-mo prepay) | Not tracked |
| Semaglutide price | from $119/mo (6-mo prepay) | from $199/mo (12-mo prepay) |
| Pharmacy receipt | Names its pharmacy (BPI Labs, Hallandale Pharmacy +5) — BPI Labs is an FDA-registered 503B outsourcing facility (federal cGMP oversight); Hallandale Pharmacy, Boudreaux's New Drug Store +2 state-verified by us in up to 15 states. Pick your state to check yours. | Names its pharmacy (Strive Pharmacy, Curexa +1) — Strive Pharmacy, RedRock Pharmacy state-verified by us in up to 17 states. Pick your state to check yours. |
| Care receipt | In-house clinicians; check-ins and coaching on record. | Care is outsourced to You Health — a contract medical group named on the clinic's own site. The brand doesn't employ your clinician. |
| Review integrity | Clean review record — 16% unprompted on 1,116 reviews, within our 40% threshold. | Review-integrity flag — 72% of its Trustpilot reviews are unprompted "organic" posts, past our 40% gaming threshold. |
| Company address | Lists a real-looking operating address on its own site. | Its listed address is a registered-agent or mailbox service — no operating location stands behind the brand's listed address. |
| Pharmacy | In review | In review |
| Clinical support | In review | In review |
| Patient support | In review | In review |
| Value | In review | In review |
| Ships to | 50 states | In review |
| Pharmacy model | Discloses its compounding pharmacies per product on its own treatments page (joinbelle.com/treatments, accessed 2026-07-15): BPI, Hallandale, Boudreaux, and VialsRx for GLP-1 products (plus Olympia for NAD+, not yet profiled here). The page also states "Belle is not the compounding pharmacy or manufacturer." | Hims is unusually vertically integrated for a GLP-1 telehealth brand: Hims & Hers Health, Inc. owns and operates its own pharmacy and manufacturing chain rather than only contracting out. Per its FY2025 Form 10-K, the company operates two licensed 503A mail-order pharmacies that fill solely for its own customers - Apostrophe Pharmacy LLC and XeCare, LLC, both now wholly-owned subsidiaries - plus a licensed 503B outsourcing facility, MedisourceRx (acquired September 2024 as Seaview Enterprises, LLC, for $31.0 million; Los Alamitos, CA), which compounded its injectable semaglutide, and a peptide manufacturing facility. The consumer Terms also name third-party partner pharmacies (EHT Pharmacy LLC dba Curexa, CD Pharmacy LLC dba Red Rock Pharmacy, AnazaoHealth Corporation, and Strive Specialties, Inc.). During the April-June 2025 Novo Nordisk bundle, brand-name Wegovy was dispensed through Novo's own NovoCare Pharmacy accessed via the Hims platform. Prescriptions are written by providers in affiliated 'You Health' professional medical groups; Hims & Hers states in its Terms that it is not itself a healthcare provider. |
| Red flags on file | 0 | 5 |
Visit joinbelle.com
Plain link, not sponsored — we take no payment for this.
Visit hims.com
Plain link, not sponsored — we take no payment for this.
Full profiles: Belle → · Hims →
State-aware license reads: the tirzepatide price board →